Incidence of IBD 10.9 per 100,000 person-years in the US

by Elana GotkineThe incidence of inflammatory bowel disease (IBD) is 10.9 per 100,000 person-years and prevalence is 721 per 100,000 population, according to a study published online July 20 inG

Updated on: May 28,2024

Incidence of IBD 10.9 per 100,000 person-years in the US

by Elana GotkineThe incidence of inflammatory bowel disease (IBD) is 10.9 per 100,000 person-years and prevalence is 721 per 100,000 population, according to a study published online July 20 inG

Updated on:May 28,2024

'Jumping genes' found to alter human colon genomes, offering insights into aging and tumorigenesis

by The Korea Advanced Institute of Science and Technology (KAIST)Genetic composition of rc-L1s is inherited from the parents. The methylation landscape of rc-L1 promoters is predominantly determi

Updated on: May 19,2024

'Jumping genes' found to alter human colon genomes, offering insights into aging and tumorigenesis

by The Korea Advanced Institute of Science and Technology (KAIST)Genetic composition of rc-L1s is inherited from the parents. The methylation landscape of rc-L1 promoters is predominantly determi

Updated on:May 19,2024

Interleukin-11 found to ameliorate acute colitis in mice

by Toho UniversityIn an undamaged large intestine, IL-11-producing cells (Yellow) are not seen. However, in the damaged area, IL-11-producing fibroblasts appear. Credit: Takashi NishinaInterleukin (IL

Updated on: June 22,2024

Interleukin-11 found to ameliorate acute colitis in mice

by Toho UniversityIn an undamaged large intestine, IL-11-producing cells (Yellow) are not seen. However, in the damaged area, IL-11-producing fibroblasts appear. Credit: Takashi NishinaInterleukin (IL

Updated on:June 22,2024

A self-powered ingestible sensor opens new avenues for gut research

by Emerson Dameron,University of California - San DiegoUC San Diego Researchers develop a self-powered ingestible sensor system designed to monitor metabolites in the small intestine over time.

Updated on: April 01,2024

A self-powered ingestible sensor opens new avenues for gut research

by Emerson Dameron,University of California - San DiegoUC San Diego Researchers develop a self-powered ingestible sensor system designed to monitor metabolites in the small intestine over time.

Updated on:April 01,2024

Von Willebrand factor antigen for assessing the urgency of a liver transplant

by Medical University of ViennaCredit: CC0 Public DomainLike most other countries, Austria—as part of the Eurotransplant organization—allocates organs to patients on the liver transplant waiting

Updated on: April 24,2024

Von Willebrand factor antigen for assessing the urgency of a liver transplant

by Medical University of ViennaCredit: CC0 Public DomainLike most other countries, Austria—as part of the Eurotransplant organization—allocates organs to patients on the liver transplant waiting

Updated on:April 24,2024

Beta-blockers display anti-inflammatory effects in advanced liver disease

by Medical University of ViennaCredit: CC0 Public DomainApproximately 170,000 people die every year in Europe from the direct consequences of advanced chronic liver disease (cirrhosis). In Austri

Updated on: May 21,2024

Beta-blockers display anti-inflammatory effects in advanced liver disease

by Medical University of ViennaCredit: CC0 Public DomainApproximately 170,000 people die every year in Europe from the direct consequences of advanced chronic liver disease (cirrhosis). In Austri

Updated on:May 21,2024

Study shows potential dangers of sweeteners

by Anglia Ruskin UniversityCredit: CC0 Public DomainNew research has discovered that common artificial sweeteners can cause previously healthy gut bacteria to become diseased and invade the gut w

Updated on: April 20,2024

Study shows potential dangers of sweeteners

by Anglia Ruskin UniversityCredit: CC0 Public DomainNew research has discovered that common artificial sweeteners can cause previously healthy gut bacteria to become diseased and invade the gut w

Updated on:April 20,2024

Digestive problems in 'long COVID' linked to psychological trauma, according research

byUniversity of OklahomaCredit: Pixabay/CC0 Public DomainMany people who were hospitalized with COVID-19 when the virus arrived in spring 2020 experienced a high rate of gastrointestinal problem

Updated on: March 27,2024

Digestive problems in 'long COVID' linked to psychological trauma, according research

byUniversity of OklahomaCredit: Pixabay/CC0 Public DomainMany people who were hospitalized with COVID-19 when the virus arrived in spring 2020 experienced a high rate of gastrointestinal problem

Updated on:March 27,2024

Using physiology to predict treatment response in eosinophilic esophagitis

by Olivia Dimmer,Northwestern UniversityCredit:Gastroenterology(2023). DOI: 10.1053/j.gastro.2023.05.031Northwestern Medicine scientists have identified and characterized clinical ou

Updated on: May 29,2024

Using physiology to predict treatment response in eosinophilic esophagitis

by Olivia Dimmer,Northwestern UniversityCredit:Gastroenterology(2023). DOI: 10.1053/j.gastro.2023.05.031Northwestern Medicine scientists have identified and characterized clinical ou

Updated on:May 29,2024

Barrett's esophagus modeled in a human organ chip

by Harvard UniversityEstablishment of homotypic tissue recombinants of human metaplastic epithelium and stromal fibroblasts isolated from patient-derived Barrett's esophagus (BE) resections a

Updated on: March 28,2024

Barrett's esophagus modeled in a human organ chip

by Harvard UniversityEstablishment of homotypic tissue recombinants of human metaplastic epithelium and stromal fibroblasts isolated from patient-derived Barrett's esophagus (BE) resections a

Updated on:March 28,2024

FDA approves Linzess to treat constipation in children, teens

by Lori SolomonThe U.S. Food and Drug Administration approvedLinzess(linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation.The appro

Updated on: February 19,2024

FDA approves Linzess to treat constipation in children, teens

by Lori SolomonThe U.S. Food and Drug Administration approvedLinzess(linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation.The appro

Updated on:February 19,2024

Eligible younger US adults less likely to meet colorectal cancer screening guidelines; face greater disparities

by University of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainYounger adults living in the U.S. are less likely to be screened for colorectal cancer than older U.S. adul

Updated on: June 20,2024

Eligible younger US adults less likely to meet colorectal cancer screening guidelines; face greater disparities

by University of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainYounger adults living in the U.S. are less likely to be screened for colorectal cancer than older U.S. adul

Updated on:June 20,2024